Skip to main content
OpenTrials
Completed

NCT Number: NCT01942005

EVER/TMC Mutation as Marker of the Risk of Cutaneous Carcinoma in Immunosuppressed Patients

Detection of mutation / specific polymorphism of the EVER/TMC6 and/or EVER/TMC8 gen.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Immunosuppression Neoplasm Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Basel, Dermatology

Basel, Canton of Basel-City, 4031, Switzerland

About this study

correlation between possibly detected mutation/specific polymorphism and kind and number of neoplasm, age of patients, UV burden, duration and kind of immunosuppression.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients in an immunosuppressive condition either by immunosuppressants or by HIV infection

Exclusion criteria

  • written informed consent not given

Treatment and study plan

Primary outcomes

  1. Detection of mutation / specific polymorphism of the EVER/TMC6 and/or EVER/TMC8 gen.

    Time frame: 7 years

Secondary outcomes

  1. correlation between possibly detected mutation/specific polymorphism of the EVER/TMC6 and/or EVER/TMC8 gen and a composite of kind and number of neoplasm, age of patients, UV burden, duration and kind of immunosuppression.

    Time frame: 7 years

Sponsors and collaborators

Lead sponsor

Andreas Arnold

Other

Registry information

Official study title

EVER/TMC Mutation as Marker of the Risk of Cutaneous Carcinoma in Immunosuppressed Patients,Especially Patients After Organ Transplantation and Patients With HIV Infection

Acronym: EBVER/TMC

Important dates

Study start
2010
Primary completion
2014
Study completion
2014
First posted
Sep 13, 2013
Registry last updated
Dec 4, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.